Bioequivalence Study of Different Formulations of Hetrombopag Olamine Tablets in Healthy Subjects
Latest Information Update: 06 Dec 2023
At a glance
- Drugs Hetrombopag (Primary)
- Indications Aplastic anaemia
- Focus Pharmacokinetics; Registrational
- Sponsors Jiangsu Hengrui Medicine Co.
- 30 Nov 2023 Status changed from active, no longer recruiting to completed.
- 27 Jun 2022 Planned End Date changed from 30 Jun 2022 to 30 Aug 2022.
- 27 Jun 2022 Planned primary completion date changed from 30 Jun 2022 to 30 Jul 2022.